Genome Editing Market Analysis, By Type (CRISPR, TALENS, ZFN)

The global Genome Editing market is expected to reach USD 10.1 billion by 2026, according to a new report by Reports and Data. Genome editing refers to a genetic engineering method used for insertion, deletion, or modification in the genome of any organism. Genome editing has come up as promising tool with wide scale application of established genetic engineering technologies such as TALEN and introduction of new methods such as CRISPR technology.

The market is driven by the increasing incidence of genetic diseases, favorable funding scenario for research & development in the field of genetic engineering, technological advancements in genetic engineering such as developments in CRISPR technology, increasing focus of food industry on genetically modified organisms, and rising awareness about efficacy as well applications of genetic engineering methods. For instance, in 2017, Synthego Corp launched its CRISPRevolution Gene Knockout Kit, a CRISPR gene editing solution. Similarly, In 2017, Thermo Fisher Scientific launched its new Invitrogen TrueEdit genome editing toolkit. Also, there is a worldwide increasing consumption of genetically modified crops which in turn supports the market growth for genome editing technologies and its applications in agriculture. However, stringent regulatory scenario and ethical concerns for gene editing research and applications and concerns among end users regarding use of gene alteration therapies are likely to hinder the market growth during the forecast period.

#crispr #healthcare #bioinformatics #geneEditing